Gooch & Housego (GHH LN) PBT up 6%, EPS up 4-5% on acquisition of ITL | Polypipe Group (PLP LN) Full year guidance reiterated in today’s interims | Realm Therapeutics (RLM LN) In-line H1s overshadowed by negative Phase II AD trial result
14 Aug 2018
Morning Song
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Song
Gooch & Housego PLC (GHH:LON), 523 | Genuit Group PLC (GEN:LON), 440 | Realm Therapeutics (RLM:LON), 0
- Published:
14 Aug 2018 -
Author:
N+1 Singer Team -
Pages:
9
Gooch & Housego (GHH LN) PBT up 6%, EPS up 4-5% on acquisition of ITL | Polypipe Group (PLP LN) Full year guidance reiterated in today’s interims | Realm Therapeutics (RLM LN) In-line H1s overshadowed by negative Phase II AD trial result